Attacking Cancer With Code And Winning - EP 48 Jake Becraft
Jake Becraft was working on mRNA way before it was cool.
In fact, Becraft’s advisors at MIT told him trying to develop therapies with mRNA would be a colossal waste of time. But, here we are in 2025, and Becraft has pushed the mRNA technology that gained so much attention during the pandemic in rather incredible new directions.
Becraft joins the podcast this week to talk about his company Strand Therapeutics and its programmable mRNA technology. Strand has developed a way to send therapies into the body and have them aim right for diseased cells. Its first clinical trial has focused on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.